Esketamine induces apoptosis of nasopharyngeal carcinoma cells through the PERK/CHOP pathway
In this study, we found that esketamine inhibited the proliferation and migration of nasopharyngeal carcinoma cells. Mechanically, transcriptome sequencing and subsequent verification experiments revealed that esketamine promoted the apoptosis of nasopharyngeal carcinoma cells through endoplasmic reticulum stress PERK/ATF4/CHOP signaling pathway mediated by NMDAR. Additionally, when combined with esketamine, the inhibitory effect of cisplatin on the proliferation of nasopharyngeal carcinoma cells was significantly enhanced. These findings provide new insights into future anti-nasopharyngeal carcinoma clinical strategies via targeting the NMDAR/PERK/CHOP axis alone or in combination with cisplatin.PMID:38219984 | DOI:10.1016/j.taap.2023.116800
Source: Toxicology and Applied Pharmacology - Category: Toxicology Authors: Yuling Cao Huiting Li Yunfei Gao Jiao Long Lei Zheng Qi Zhang Ningning Li Xinjin Chi Source Type: research
More News: African Health | Anesthesia | Anesthesiology | Cancer & Oncology | Carcinoma | Drugs & Pharmacology | Nasopharyngeal Cancer | Study | Toxicology